Skip to main content
Molecular & Cellular Oncology logoLink to Molecular & Cellular Oncology
. 2015 Jul 29;3(2):e1074332. doi: 10.1080/23723556.2015.1074332

CHCHD4 links AIF to the biogenesis of respiratory chain complex I

Nazanine Modjtahedi a,b,c,d,✉,*, Guido Kroemer a,b,c,e,f,g,h,
PMCID: PMC4905392  PMID: 27308594

ABSTRACT

During the evolution from yeast to mammals the Mia40 protein, the regulator of the redox-sensitive mitochondrial intermembrane space import machinery, has lost its membrane-anchorage segment to become CHCHD4, which interacts with the flavoprotein apoptosis-inducing factor (AIF). Our results establish CHCHD4 as the missing link between AIF deficiency and dysfunctional biogenesis of respiratory chain complexes.

KEYWORDS: Disulfide relay, mitochondrial import, mitochondriopathy, respiratory chain complexes


Mitochondrial diseases are a group of heterogeneous inherited metabolic disorders that affect 1 in 5,000 individuals and are essentially caused by defects in the mitochondrial oxidative phosphorylation machinery.1 Our poor understanding of these diseases and the lack of efficient therapeutic solutions reflect the uniqueness of the respiratory chain, which is the only metabolic machinery under the dual control of nuclear and mitochondrial genes. Among the 90 subunits that constitute the 5 respiratory chain complexes (CI to CV), 13 subunits are encoded by the mitochondrial DNA whereas the additional 77 are nuclear encoded and imported into the organelle.1 Moreover, optimal performance of the organelle requires the import of more than 1,000 additional nuclear-encoded proteins that are indispensible for the biogenesis and/or the assembly of respiratory chain complexes, expression of the mitochondrial genome, regulation of mitochondrial ultrastructure, the finely tuned movement of mitochondria, and for crosstalk between the organelle and the nuclear compartment.1,2

Approximately 30% of human mitochondriopathies affect the complex CI (nicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase; EC 1.6.5.3), a multiprotein complex that is composed of 7 mitochondrial- and 38 nuclear-encoded subunits and requires a series of “assembly factors” that are not contained in the mature complex for its assembly and maturation. One of the nuclear-encoded mitochondrial proteins that has been listed in the category of CI assembly factors is the redox-active flavoprotein apoptosis-inducing factor (AIF) that was initially discovered as a proapoptotic protein.3 In mitochondria from healthy cells AIF is confined to the intermembrane space (IMS). In all investigated species, the loss or downregulation of AIF provokes severe CI-related respiratory defects that are caused by a post-translational loss of CI protein subunits.3 Although complex CI remains the primary target of AIF dysfunction, losses of complex CIII (ubiquinol cytochrome c reductase; EC 1.10.2.2) and CIV (cytochrome c oxidase; EC 1.9.3.1) subunits were also observed in specific cell types.3 In humans, mutations in AIF have been associated with severe X-linked pediatric mitochondriopathies.4-6

The recent isolation of the first mitochondrial interactor of AIF, a protein called coiled-coil-helix-coiled-coil-helix domain containing 4 (CHCHD4), has shed new light on the mitochondrial activity of AIF.7 CHCHD4, which is the human homolog of yeast mitochondrial intermembrane space import and assembly protein 40 (Mia40),8 plays a central role in the import and oxidative folding of a group of small nuclear-encoded proteins (substrates) that essentially carry 2 cysteine-x3-cysteine (Cx3C)2 or 2 cysteine-x9-cysteine (Cx9C)2 motifs and participate in a large panel of heterogeneous activities in the IMS8-10 (Table 1). Given the vast number of mitochondrial processes that are covered by potential CHCHD4 substrates8-10 (Table 1), AIF cannot be solely considered as a complex CI assembly factor but rather as a central component of the redox-active CHCHD4-dependent import machinery that, in addition to the biogenesis of respiratory chain subunits,7 has the capacity to regulate additional processes ranging from protein import to intramitochondrial lipid homeostasis, antioxidant response, mitochondrial translation, or mitochondrial membrane organization.

Table 1.

Human proteins containing 2 (Cx9C) and 2 (Cx3C) motifs*.

Symbol Synonyms Accession number Cysteine motif Function# Chromosomal location
CHCHD1 FLJ25854 NP_976043 Cx9C-Cx9C Mitochondrial translation 10q22.3
CHCHD3 MINOS3; Mic19 NP_060282.1 Cx9C-Cx9C MICOS complex 7q33
CHCHD6 CHCM1; Mic25 NP_115719.1 Cx9C-Cx9C MICOS complex 3q21.3
CHCHD4 MIA40; TIMM40 NP_001091972.1 Cx9C-Cx9C IMS redox-regulated import 3p25.1
CHCHD10 N27C7–4 NP_001288268.1 Cx9C-Cx9C Cristae morphology 22q11.23
NDUFA8 PGIV NP_055037.1 Cx9C-Cx9C CI subunit 9q33.2
NDUFB7 B18 NP_004137.2 Cx9C-Cx9C CI subunit 19p13.12
NDUFS5 CI-15k NP_001171908.1 Cx9C-Cx9C CI subunit 1p34.3
UQCRH QCR6 AAH93060 Cx10C-Cx9C CIII subunit 1p34.1
COX6B1 COXG NP_001854.1 Cx9C-Cx10C CIV subunit 19q13.12
COX6B2 CT59 NP_653214.2 Cx9C-Cx10C CIV subunit 19q13.42
COX17   NP_005685.1 Cx9C-Cx9C CIV copper chaperone 3q13.33
COX19 MGC104475 NP_001026788 Cx9C-Cx9C CIV copper chaperone 7p22.3
CHCHD7 COX23 NP_001011668 Cx9C-Cx9C CIV copper chaperone 8q11.23
COA4 CMC3; E2IG2 NP_057649.2 Cx9C-Cx9C CIV assembly factor 11q13.4
COA5 FLJ27524; Pet191 NP_001008216 Cx9C-Cx10C CIV assembly factor 2q11.2
COA6   NP_001013003.1 Cx9C-Cx10C CIV assembly factor 1q42.2
CMC1 MGC61571 NP_872329 Cx9C-Cx9C CIV biogenesis 3p24–1
CMC2 MGC45036; DC13 NP_064573 Cx9C-Cx9C CIV biogenesis 16q23.2
CHCHD2   NP_057223 CX9C-CX9C CIV subunit expression and assembly 7p11.2
TRIAP1 MDM35 NP_057483 Cx9C-Cx9C Mitochondrial lipid homeostasis 12q24.31
CHCHD5 MIC14 NP_115685.1 Cx9C-Cx9C Unknown 2q14.1
CMC4 P8MTCP1 NP_001018024.1 Cx9C-Cx9C Unknown Xq28
UPF0545   NP_776154 Cx9C-Cx9C Unknown 22q11.21
C17orf89   NP_001079990.1 Cx9C-Cx9C Unknown 17q25.3
TIMM8A DDP1 NP_001139423.1 Cx3C-Cx3C Protein import Xq22.1
TIMM8B DDP2 NP_036591.2 Cx3C-Cx3C Protein import 11q23.1
TIMM9 TIM9A NP_001291414.1 Cx3C-Cx3C Protein import 14q23.1
TIMM10 TIM10A NP_036588.1 Cx3C-Cx3C Protein import 11q12.1
TIMM10B TIM10B; Tim9B NP_036324.1 Cx3C-Cx3C Protein import 11p15.4
TIMM13 Tim13 NP_036590.1 Cx3C-Cx3C Protein import 19p13.3
*

Data have been extracted from References 8 to 10, as well as from public databases.

CI, respiratory chain complex CI; CIII, respiratory chain complex CIII; CIV, respiratory chain complex CIV; IMS, intermembrane space; MICOS, mitochondrial contact site.

Obviously, for a better understanding of the molecular impact of AIF activity on the CHCHD4-dependent import pathway, several questions need to be answered in the future. For instance, co-crystalization of AIF and CHCHD4 will reveal how AIF affects the structural maturation of CHCHD4 and its interaction with cofactors, its substrates, and its redox recycling partner, the sulfhydryl oxidase ERV1/ALR.8 The second question concerns the organo-specific impact of AIF deficiency on the biogenesis of specific respiratory chain complexes. Such tissue specificity is well described in the case of the AIF hypomorphic Harlequin (Hq) mouse model.3 CI deficiency was detected only in the brain and retina of Hq mice, but not in other organs, correlating with the tissue-specific degeneration that characterizes the phenotype of this mouse model.3 Is this peculiarity explainable by tissue-specific expression of certain CHCHD4 substrates? During the evolution from yeast to mammals, (Cx9C)2 motif-containing proteins have almost doubled in number. Beyond the evolutionary-conserved substrates implicated in the biogenesis of complex CIV (conserved between yeast and mammals), substrates corresponding to the subunits of complex CI (absent from yeast) have made their appearance (Table 1). An in-depth characterization of CHCHD4 substrates and their redox-regulated mitochondrial import in mammals should help us better understand the tissue-specific effect of AIF dysfunction on CI. Is this effect caused by the loss of CI subunits that are directly imported in a CHCHD4-dependent manner or is it an indirect effect provoked by the loss of other substrates? As recent progress in the field tends to support the notion that the assembly of complex CI is dependent on the formation of supercomplexes with CIII and CIV, an open alternative question concerns the potential crosstalk between complexes CI and CIV to explain the phenotype of AIF-deficient cells.

The molecular characterization of the physical and function interaction between AIF and CHCHD4 may spur new therapeutic strategies for the correction of respiratory defects that are caused by the loss or downregulation of AIF. As our results show that in vitro transfection of cells with a modified CHCHD4 whose mitochondrial import does not rely on AIF can repair the respiratory defect of AIF-deficient cells,7 we believe that strategies for the correction of CHCHD4-dependent import pathway should be considered as a potential therapeutic strategy for the treatment of mitochondriopathies that are caused by the loss or downregulation of AIF.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Funding

This research was supported by French National Research Agency.

References

  • 1.Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 2012; 13:878-90; PMID:23154810; http://dx.doi.org/ 10.1038/nrg3275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, et al. . A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134:112-23; PMID:18614015; http://dx.doi.org/ 10.1016/j.cell.2008.06.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hangen E, Blomgren K, Benit P, Kroemer G, Modjtahedi N. Life with or without AIF. Trends Biochem Sci 2010; 35:278-87; PMID:20138767; http://dx.doi.org/ 10.1016/j.tibs.2009.12.008 [DOI] [PubMed] [Google Scholar]
  • 4.Modjtahedi N, Giordanetto F, Kroemer G. A human mitochondriopathy caused by AIF mutation. Cell Death Differ 2010; 17:1525-8; PMID:20835254; http://dx.doi.org/ 10.1038/cdd.2010.88 [DOI] [PubMed] [Google Scholar]
  • 5.Berger I, Ben-Neriah Z, Dor-Wolman T, Shaag A, Saada A, Zenvirt S, Raas-Rothschild A, Nadjari M, Kaestner KH, Elpeleg O. Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab 2011; 104:517-20; PMID:22019070; http://dx.doi.org/ 10.1016/j.ymgme.2011.09.020 [DOI] [PubMed] [Google Scholar]
  • 6.Rinaldi C, Grunseich C, Sevrioukova IF, Schindler A, Horkayne-Szakaly I, Lamperti C, Landouré G, Kennerson ML, Burnett BG, Bönnemann C, et al. . Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. Am J Hum Genet 2012; 91:1095-102; PMID:23217327; http://dx.doi.org/ 10.1016/j.ajhg.2012.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hangen E, Feraud O, Lachkar S, Mou H, Doti N, Fimia GM, Lam NV, Zhu C, Godin I, Muller K, et al. . Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis. Mol Cell 2015; 58:1001-14; PMID:26004228; http://dx.doi.org/ 10.1016/j.molcel.2015.04.020 [DOI] [PubMed] [Google Scholar]
  • 8.Herrmann JM, Riemer J. Three approaches to one problem: protein folding in the periplasm, the endoplasmic reticulum, and the intermembrane space. Antioxid Redox Signal 2014; 21:438-56; PMID:24483706; http://dx.doi.org/ 10.1089/ars.2014.5841 [DOI] [PubMed] [Google Scholar]
  • 9.Longen S, Bien M, Bihlmaier K, Kloeppel C, Kauff F, Hammermeister M, Westermann B, Herrmann JM, Riemer J. Systematic analysis of the twin cx(9)c protein family. J Mol Biol 2009; 393:356-68; PMID:19703468; http://dx.doi.org/ 10.1016/j.jmb.2009.08.041 [DOI] [PubMed] [Google Scholar]
  • 10.Cavallaro G. Genome-wide analysis of eukaryotic twin CX9C proteins. Mol Biosyst 2010; 6:2459-70; PMID:20922212; http://dx.doi.org/ 10.1039/c0mb00058b [DOI] [PubMed] [Google Scholar]

Articles from Molecular & Cellular Oncology are provided here courtesy of Taylor & Francis

RESOURCES